Antimyoclonic Action of Piracetam
- 1 February 1986
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 9 (1) , 58-64
- https://doi.org/10.1097/00002826-198602000-00006
Abstract
Five patients with myoelonus were treated with oral piracetam (8–9 g/day). All patients had action-sensitive and/or stimulus-sensitive myoclonus and enhanced amplitude of somatosensory evoked potentials. Piracetam produced a marked reduction of the myoclonus in the five subjects without side effects. In view of its excellent tolerance and synergism with other antimyoclonic drugs, we consider piracetam to be a very valuable drug for the treatment of patients with myoelonus of any origin.Keywords
This publication has 0 references indexed in Scilit: